Start-Up Spotlight: Allelica Offers Personalized Medicine Via Genomic Sequencing
Allelica, a company specializing in diagnostics "software as a service," has obtained $1.75m in seed funding to bring genomic risk prediction to the forefront of patient care.
You may also be interested in...
SUMMIT, the landmark study conducted within the UK focused on diagnosing lung cancer before it becomes untreatable, has demonstrated the practicality and cost effectiveness of mass CT screening.
Prescience Point Capital is trying to reshuffle the board of directors leading regenerative medicine company MiMedx, arguing the company’s current board has destroyed shareholder value. The company's tock is selling for about a third of its potential value, according to Prescience.
As wearable medical devices become increasingly common for more and more complex applications, developers are facing questions are about the industry’s direction and how they will protect consumers.